Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 144
Keywords: Cisplatin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Comparing the Efficacy of a Triplet Antiemetic Regimen in Patients with Esophageal Cancer and Diabetes Mellitus Treated with Cisplatin-Based Chemotherapy: A Retrospective Study
Available to PurchaseSubject Area:
Oncology
Masahiro Hatori, Shota Fukuoka, Shunya Kimura, Kazuyoshi Kawakami, Kensei Yamaguchi, Masakazu Yamaguchi
Journal:
Oncology
Oncology 1–9.
Published Online: 07 December 2024
...Masahiro Hatori; Shota Fukuoka; Shunya Kimura; Kazuyoshi Kawakami; Kensei Yamaguchi; Masakazu Yamaguchi Introduction: Cisplatin-based highly emetogenic chemotherapy is recommended in combination with neurokinin-1 receptor antagonist, 5-hydroxytryptamine-3-receptor antagonist (5HT3RA), dexamethasone...
Journal Articles
Effect of Hydration with Bicarbonate Ringer’s Solution on Cisplatin-Induced Acute Kidney Injury in Patients with Esophageal Cancer: A Retrospective Cohort Study
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2025) 103 (1): 22–29.
Published Online: 29 July 2024
...Miho Takemura; Kenji Ikemura; Masahiro Okuda Introduction: Cisplatin (CDDP) often causes acute kidney injury (AKI), and magnesium supplementation has been suggested to be important in preventing CDDP-induced AKI. Sodium bicarbonate Ringer’s solution (BRS) is a crystalloid solution composed...
Journal Articles
Subject Area:
Oncology
Shogo Kobayashi, Hiroshi Wada, Daisuke Sakai, Hideo Baba, Masashi Kanai, Hirofumi Kamachi, Tadatoshi Takayama, Masaki Ueno, Masahiro Takahashi, Masayuki Sho, Kenichi Yoshimura, Etsuro Hatano, Hiroaki Nagano, Tatsuya Ioka, on behalf of Kansai Hepato-Biliary Oncology (KHBO) Group
Journal:
Oncology
Oncology (2024) 102 (6): 447–456.
Published Online: 04 December 2023
...: The multicenter randomized phase III KHBO1401 study (gemcitabine+cisplatin+S-1 [GCS] vs. GC in biliary tract cancers [BTC]) demonstrated that GCS not only prolonged patient survival but also achieved a high response rate and that it should be good for neoadjuvant therapy. Therefore, to explore the possibilities...
Journal Articles
Subject Area:
Oncology
Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Keigo Komine, Tomoyuki Iwasaki, Noriko Takenaga, Yuki Kasahara, Kota Ouchi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Journal:
Oncology
Oncology (2024) 102 (5): 359–367.
Published Online: 30 October 2023
... with platinum and etoposide combination therapy as first-line chemotherapy. However, it remains uncertain whether carboplatin and etoposide combination therapy (CE) and cisplatin and etoposide combination therapy (PE) have comparable treatment efficacy. In this retrospective analysis, we compared the efficacy...
Journal Articles
Subject Area:
Oncology
Kodai Kawamura, Hidekazu Matsushima, Hiroshi Sakai, Akira Iwashima, Sukeyuki Nakamura, Tohru Kojima, Shinichi Sasaki, Takehiko Shigenaga, Ichiro Natsume, Takaaki Sasaki, Yoshinobu Ohsaki, Kentaro Iwanaga, Koichi Nishi, Yoichiro Mitsuishi, Hirokazu Taniguchi, Kazuhiro Sato, Mitsugu Yamauchi, Motowo Nakajima, Kazuhisa Takahashi
Journal:
Oncology
Oncology (2022) 100 (11): 620–632.
Published Online: 13 September 2022
... Nakajima; Kazuhisa Takahashi Introduction: Cisplatin-based chemotherapy was established in the 1980s, and it has been improved by the development of a short hydration protocol in lung cancer therapy. However, cisplatin-based chemotherapy is still associated with renal toxicity. Because 5-aminolevulinic...
Journal Articles
Subject Area:
Oncology
Di Maria Jiang, Hao-Wen Sim, Osvaldo Espin-Garcia, Bryan A. Chan, Akina Natori, Charles H. Lim, Stephanie Moignard, Eric X. Chen, Geoffrey Liu, Gail Darling, Carol J. Swallow, Savtaj Brar, James Brierley, Jolie Ringash, Rebecca Wong, John Kim, Patrik Rogalla, Sara Hafezi-Bakhtiari, Jennifer J. Knox, Raymond W. Jang, Elena Elimova
Journal:
Oncology
Oncology (2021) 99 (1): 49–56.
Published Online: 14 October 2020
... with cisplatin plus fluorouracil (CF) can be used. Definitive chemoradiotherapy (dCRT) with CP or CF can be used if surgery is not planned. In the absence of comparative trials, we aimed to evaluate outcomes of CP and CF in the settings of TMT and dCRT. Methods: A single-site, retrospective cohort study...
Journal Articles
Risk Factors for Cisplatin-Induced Nephrotoxicity: A Multicenter Retrospective Study
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2021) 99 (2): 105–113.
Published Online: 23 September 2020
...Takanori Miyoshi; Miyuki Uoi; Fuyuki Omura; Kyouichi Tsumagari; Sachi Maesaki; Chiaki Yokota Introduction: Cisplatin (CDDP)-induced nephrotoxicity is a concern in CDDP-based chemotherapy. The goal of this multicenter retrospective study was to identify potential risk factors for CDDP nephrotoxicity...
Journal Articles
Prophylactic Effect of Premedication with Intravenous Magnesium on Renal Dysfunction in Preoperative Cisplatin-Based Chemotherapy for Esophageal Cancer
Available to PurchaseSubject Area:
Oncology
Yuto Kubo, Hiroshi Miyata, Keijiro Sugimura, Naoki Shinno, Hajime Ushigome, Yoshitomo Yanagimoto, Yusuke Takahashi, Kazuyoshi Yamamoto, Junichi Nishimura, Hiroshi Wada, Hidenori Takahashi, Masayoshi Yasui, Takeshi Omori, Masayuki Ohue, Masahiko Yano
Journal:
Oncology
Oncology (2019) 97 (6): 319–326.
Published Online: 25 September 2019
... to have a significant effect on reducing cisplatin-induced nephrotoxicity in several types of cancer. However, the effectiveness of magnesium administration in reducing nephrotoxicity remains unknown in esophageal cancer, especially regarding neoadjuvant therapy. Methods: Between January 2017 and January...
Journal Articles
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302
Available to PurchaseSubject Area:
Oncology
Satoshi Ikeda, Hiroshige Yoshioka, Toshihiko Kaneda, Toshihide Yokoyama, Takashi Niwa, Naoyuki Sone, Tadashi Ishida, Mitsunori Morita, Hiromi Tomioka, Chihito Komaki, Masataka Hirabayashi, Yoshinori Hasegawa, Tetsuo Noguchi, Yasutaka Nakano, Chikara Sakaguchi, Kenichi Yoshimura, Toyohiro Hirai
Journal:
Oncology
Oncology (2019) 97 (6): 327–333.
Published Online: 14 August 2019
... Background: There has been no study so far on gemcitabine continuous maintenance therapy targeting only squamous non-small-cell lung cancer (NSCLC) patients. This study aimed to assess the efficacy and safety of cisplatin plus gemcitabine followed by maintenance gemcitabine for chemotherapy- naïve Japanese...
Journal Articles
Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus
Available to PurchaseSubject Area:
Oncology
Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Masahiro Katsuda, Keiji Hayata, Shimpei Maruoka, Toshio Shimokawa, Hiroki Yamaue
Journal:
Oncology
Oncology (2018) 95 (2): 116–120.
Published Online: 16 May 2018
...Toshiyasu Ojima; Masaki Nakamura; Mikihito Nakamori; Masahiro Katsuda; Keiji Hayata; Shimpei Maruoka; Toshio Shimokawa; Hiroki Yamaue Our previous trial with a docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen showed high response rates in metastatic squamous cell carcinoma of the esophagus...
Journal Articles
First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2018) 94 (5): 324–328.
Published Online: 13 March 2018
... evaluate the activity of an association of 1G3-Cu with 5 cytotoxic agents used in chemotherapy having different modes of action. Data show no additive effect with camptothecin and cisplatin, additivity with paclitaxel and MG132, and synergy with doxorubicin. Results suggest that the multivalent Cu...
Journal Articles
The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer
Available to PurchaseMiguel Caballero, Paula Mackers, Oscar Reig, Elvira Buxo, Pilar Navarrete, Jose L. Blanch, Juan J. Grau
Journal:
Oncology
Oncology (2017) 93 (2): 75–82.
Published Online: 17 May 2017
... cisplatin (100 mg/m 2 ) between January 2013 and February 2015 were enrolled. Audiometry was performed at baseline and before cisplatin. Change to a less ototoxic agent or reduced cisplatin dose was considered with audiometric decreases >25 dB. Results: A total of 103 patients were included; the median...
Journal Articles
Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity
Available to PurchaseTomohiro Mizuno, Takahiro Hayashi, Yuka Shimabukuro, Maho Murase, Hiroki Hayashi, Kazuhiro Ishikawa, Kazuo Takahashi, Yukio Yuzawa, Shigeki Yamada, Tadashi Nagamatsu
Journal:
Oncology
Oncology (2016) 90 (6): 313–320.
Published Online: 27 May 2016
...Tomohiro Mizuno; Takahiro Hayashi; Yuka Shimabukuro; Maho Murase; Hiroki Hayashi; Kazuhiro Ishikawa; Kazuo Takahashi; Yukio Yuzawa; Shigeki Yamada; Tadashi Nagamatsu Background and Aims: Cisplatin-induced nephrotoxicity primarily occurs in the proximal tubules, and tubular injuries reduce...
Journal Articles
Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation
Available to PurchaseSubject Area:
Oncology
Marco Ciaparrone, Orietta Caspiani, Giulio Bicciolo, Diego Signorelli, Ilaria Simonelli, Luca de Campora, Giorgio Mazzarella, Antonella Mecozzi, Curzio Pianelli, Angelo Camaioni, Piera Catalano, Patrizio Pasqualetti, Alfredo Fabiano, Marco Radici, Luca Marmiroli, Domenico Cristiano Corsi
Journal:
Oncology
Oncology (2015) 89 (4): 227–234.
Published Online: 09 June 2015
... resected HNSCC patients who underwent surgery and cisplatin chemoradiation. Methods: ERCC1 expression levels were determined by immunohistochemistry in primary tumor tissues from 48 patients with stage III-IV cancers. The median follow-up was 38.5 months (range: 5-121). Results: High ERCC1 expression...
Journal Articles
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study
Available to PurchaseSubject Area:
Oncology
Pierluigi Benedetti Panici, Innocenza Palaia, Claudia Marchetti, Ilary Ruscito, Margherita Fischetti, Angela Musella, Violante Di Donato, Giorgia Perniola, Laura Vertechy, Ludovico Muzii
Journal:
Oncology
Oncology (2015) 89 (2): 103–110.
Published Online: 29 April 2015
...Pierluigi Benedetti Panici; Innocenza Palaia; Claudia Marchetti; Ilary Ruscito; Margherita Fischetti; Angela Musella; Violante Di Donato; Giorgia Perniola; Laura Vertechy; Ludovico Muzii Objective: To assess the efficacy and toxicity profile of dose-dense cisplatin-based neoadjuvant chemotherapy...
Journal Articles
Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer
Available to PurchaseSubject Area:
Oncology
Chikara Kunisaki, Hirochika Makino, Jun Kimura, Ryo Takagawa, Amane Kanazawa, Mitsuyoshi Ota, Takashi Kosaka, Hidetaka A. Ono, Hirotoshi Akiyama, Itaru Endo
Journal:
Oncology
Oncology (2015) 88 (5): 281–288.
Published Online: 14 January 2015
... of neoadjuvant chemotherapy prior to gastrectomy. Methods: Two cycles of a 3-week regimen of fluoropyrimidine S-1 (40 mg/m 2 , orally, twice daily), together with cisplatin (60 mg/m 2 , intravenously, day 8), were administered to patients, separated by a 2-week rest period. Surgery was performed 3 weeks later...
Journal Articles
Subject Area:
Oncology
Ying-Chun Shen, Chung-Pin Li, Chia-Jui Yen, Chiun Hsu, Yu-Lin Lin, Zhong-Zhe Lin, Li-Tzong Chen, Wu-Chou Su, Yee Chao, Kun-Huei Yeh, Ann-Lii Cheng
Journal:
Oncology
Oncology (2014) 87 (2): 104–113.
Published Online: 04 July 2014
...Ying-Chun Shen; Chung-Pin Li; Chia-Jui Yen; Chiun Hsu; Yu-Lin Lin; Zhong-Zhe Lin; Li-Tzong Chen; Wu-Chou Su; Yee Chao; Kun-Huei Yeh; Ann-Lii Cheng Objective: This phase II trial investigates the efficacy and safety of low-dose everolimus in combination with cisplatin-fluorouracil chemotherapy...
Journal Articles
Renal Toxicity Associated with Weekly Cisplatin and Gemcitabine Combination Therapy for Treatment of Advanced Biliary Tract Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2014) 87 (1): 30–39.
Published Online: 25 June 2014
...Satoshi Kobayashi; Makoto Ueno; Shinichi Ohkawa; Kuniyasu Irie; Yoshihiro Goda; Manabu Morimoto Objective: A combination of weekly cisplatin plus gemcitabine is a new standard regimen for patients with advanced biliary tract cancer (BTC). This regimen does not require prolonged hydration schedules...
Journal Articles
The Risk Factors of Severe Acute Kidney Injury Induced by Cisplatin
Available to PurchaseTomohiro Mizuno, Kazuhiro Ishikawa, Waichi Sato, Takahiro Koike, Mayu Kushida, Yasuhiro Miyagawa, Kiyofumi Yamada, Sumio Hirata, Enyu Imai, Yukihiro Noda
Journal:
Oncology
Oncology (2013) 85 (6): 364–369.
Published Online: 07 December 2013
... injury (AKI) caused by cisplatin. The purpose of this study was to investigate risk factors of severe cisplatin-induced AKI (CIA). Methods: From January 2006 to December 2012, we identified Japanese cancer patients who were treated with cisplatin as a first-line chemotherapy at Nagoya University Hospital...
Journal Articles
Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Available to PurchaseSubject Area:
Oncology
Jessica Ley, Paul Mehan, Tanya M. Wildes, Wade Thorstad, Hiram A. Gay, Loren Michel, Brian Nussenbaum, Kathryn Trinkaus, Douglas Adkins
Journal:
Oncology
Oncology (2013) 85 (5): 290–296.
Published Online: 06 November 2013
...Jessica Ley; Paul Mehan; Tanya M. Wildes; Wade Thorstad; Hiram A. Gay; Loren Michel; Brian Nussenbaum; Kathryn Trinkaus; Douglas Adkins Objective: Whether or not cisplatin and cetuximab are similarly effective in improving outcomes when added to radiation therapy (RT) in squamous cell carcinoma...
1